CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,415,000 | +35.9% | 35,370 | -25.7% | 0.46% | +16.9% |
| Q3 2020 | $3,984,000 | +5.5% | 47,630 | -7.3% | 0.40% | +7.3% |
| Q2 2020 | $3,775,000 | +51.7% | 51,370 | -12.4% | 0.37% | +32.3% |
| Q1 2020 | $2,488,000 | -30.4% | 58,670 | 0.0% | 0.28% | -18.2% |
| Q4 2019 | $3,573,000 | +35.1% | 58,670 | -9.1% | 0.34% | +27.7% |
| Q3 2019 | $2,645,000 | -13.0% | 64,530 | 0.0% | 0.27% | +17.6% |
| Q2 2019 | $3,039,000 | – | 64,530 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |